Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Top Ranked Value Stocks To Buy For July 22nd

Published 07/21/2019, 11:28 PM
Updated 07/09/2023, 06:31 AM
DAL
-

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 22nd:

Delta Air Lines (NYSE:DAL), Inc. (DAL): This scheduled air transportation provider for passengers and cargo has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.7% over the last 60 days.

Delta Air Lines has a price-to-earnings ratio (P/E) of 8.66, compared with 10.30 for the industry. The company possesses a Value Score of A.

Elevate Credit, Inc. (ELVT): This provider of online credit solutions to non-prime consumers has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 3.4% over the last 60 days.

Elevate Credit has a price-to-earnings ratio (P/E) of 7.07, compared with 8.60 for the industry. The company possesses a Value Score of A.

Hawaiian Holdings, Inc. (HA): This provider of scheduled air transportation of passengers and cargo has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 4.5% over the last 60 days.

Hawaiian Holdings has a price-to-earnings ratio (P/E) of 6.96, compared with 10.30 for the industry. The company possesses a Value Score of A.

Mr. Cooper Group Inc. (COOP): This transaction-based services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 3.3% over the last 60 days.

Mr. Cooper has a price-to-earnings ratio (P/E) of 4.90 compared with 8.60 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Hawaiian Holdings, Inc. (HA): Free Stock Analysis Report

Elevate Credit, Inc. (ELVT): Free Stock Analysis Report

Delta Air Lines, Inc. (DAL): Free Stock Analysis Report

MR. COOPER GROUP INC (COOP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.